RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Lexapro (drug) (INACTIVE)

A collection of news and information related to Lexapro (drug) (INACTIVE) published by this site and its partners.

Top Lexapro (drug) (INACTIVE) Articles see all

Displaying items 1-5
  • New therapies offer bright hope against the darkness of depression

     New therapies offer bright hope against the darkness of depression
    The numbers are staggering: Almost 7% of the U.S. adult population — about 17.6 million people — is diagnosed with depression, according to the National Institute of Mental Health. The national Centers for Disease Control and Prevention report that depression costs 200 million lost workdays each year at a cost to employers of $17 billion to $44 billion.
  • Ned Vizzini: Writers and friends pay tribute

    Ned Vizzini: Writers and friends pay tribute
    Ned Vizzini, who died Thursday at the age of 32, was a successful YA author of books such as "It's Kind of a Funny Story" and "The Other Normals," who had recently expanded into Hollywood film and television. We asked a few writers who knew him to share...

    Bob Filner gets probation -- and his secrets are now public record

    Bob Filner gets probation -- and his secrets are now public record
    Hello probation. Goodbye dignity. Monday's coda to the career implosion of former San Diego Mayor Bob Filner is yet another cautionary tale for powerful men: You could end up like Filner, jobless and disgraced, with your deepest secrets laid out in...

    Robinson Calcagnie Robinson Shapiro Davis, Inc.

    Robinson Calcagnie Robinson Shapiro Davis, Inc.
    The law firm of Robinson Calcagnie Robinson Shapiro Davis, Inc. has built a national reputation for providing the highest quality of legal representation and obtaining substantial jury verdicts, judgments and settlements. Since 1978, when senior...

    FDA approves a new antidepressant: Brintellix

    FDA approves a new antidepressant: Brintellix
    The Food and Drug Administration late Monday approved a new antidepressant medication that is a novel variant on the selective serotonin reuptake inhibitors, or SSRIs, that have become the mainstay of depression treatment. The drug, whose generic chemical...